Since IL-6 is a pleiotropic cytokine and plays a role in immune regulation of the tumor microenvironment20, we then explored the potential link between IL-6 expression and the CD73-adenosine axis, one of the key metabolic pathways or immune checkpoints that regulate tumor immunity21, 22. The gene discussed is NT5E; the disease is neoplasm.